Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Mi Wi

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Diagnostic Microbiology and Infectious Disease|December 4, 2015
Comparison of the microbiological characteristics and virulence factors of ST131 and non-ST131 clones among extended-spectrum β-lactamase-producing Escherichia coli causing bacteremiaMin Kyeong Cha, Cheol-In Kang, So Hyun Kim, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 11, 2015
Clinical Features and Treatment Outcomes of Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131Sun Young Cho, Cheol-In Kang, Min Kyeong Cha, et al.
International Journal of Antimicrobial Agents|September 28, 2013
Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancerYoung Eun Ha, Cheol-In Kang, Min Kyeong Cha, et al.
Journal of Korean Medical Science|July 16, 2013
Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year periodCheol-In Kang, Min Kyeong Cha, So Hyun Kim, et al.
International Journal of Antimicrobial Agents|May 29, 2012
High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemiaYu Mi Wi, June Myung Kim, Eun-Jeong Joo, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|June 30, 2012
Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniaeSo Yeon Park, Cheol-In Kang, Eun-Jeong Joo, et al.
Journal of Clinical Medicine|February 13, 2026
Comparison of Tuberculosis Exposure Frequency and Latent Tuberculosis Infection Rates Among Healthcare Workers by Occupational ClassificationSeran Cheon, Si-Ho Kim, Ji Hong Park, et al.
Journal of Korean Medical Science|February 12, 2025
Effects of Cessation of Single-Room Isolation on Transmission of Vancomycin-Resistant <i>Enterococcus</i> in a HospitalSi-Ho Kim, Yu Jin Lee, Ji Hong Park, et al.
Scandinavian Journal of Infectious Diseases|April 2, 2011
Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritisYoung Eun Ha, Cheol-In Kang, Eun-Jeong Joo, et al.
Journal of Korean Medical Science|December 21, 2021
Clinical Features of Adult COVID-19 Patients without Risk Factors before and after the Nationwide SARS-CoV-2 B.1.617.2 (Delta)-variant Outbreak in Korea: Experience from Gyeongsangnam-doByung-Han Ryu, Sun In Hong, Su Jin Lim, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Diagnostic Microbiology and Infectious Disease|December 4, 2015
Comparison of the microbiological characteristics and virulence factors of ST131 and non-ST131 clones among extended-spectrum β-lactamase-producing Escherichia coli causing bacteremiaMin Kyeong Cha, Cheol-In Kang, So Hyun Kim, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 11, 2015
Clinical Features and Treatment Outcomes of Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131Sun Young Cho, Cheol-In Kang, Min Kyeong Cha, et al.
International Journal of Antimicrobial Agents|September 28, 2013
Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancerYoung Eun Ha, Cheol-In Kang, Min Kyeong Cha, et al.
Journal of Korean Medical Science|July 16, 2013
Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year periodCheol-In Kang, Min Kyeong Cha, So Hyun Kim, et al.
International Journal of Antimicrobial Agents|May 29, 2012
High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemiaYu Mi Wi, June Myung Kim, Eun-Jeong Joo, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|June 30, 2012
Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniaeSo Yeon Park, Cheol-In Kang, Eun-Jeong Joo, et al.
Journal of Clinical Medicine|February 13, 2026
Comparison of Tuberculosis Exposure Frequency and Latent Tuberculosis Infection Rates Among Healthcare Workers by Occupational ClassificationSeran Cheon, Si-Ho Kim, Ji Hong Park, et al.
Journal of Korean Medical Science|February 12, 2025
Effects of Cessation of Single-Room Isolation on Transmission of Vancomycin-Resistant <i>Enterococcus</i> in a HospitalSi-Ho Kim, Yu Jin Lee, Ji Hong Park, et al.
Scandinavian Journal of Infectious Diseases|April 2, 2011
Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritisYoung Eun Ha, Cheol-In Kang, Eun-Jeong Joo, et al.
Journal of Korean Medical Science|December 21, 2021
Clinical Features of Adult COVID-19 Patients without Risk Factors before and after the Nationwide SARS-CoV-2 B.1.617.2 (Delta)-variant Outbreak in Korea: Experience from Gyeongsangnam-doByung-Han Ryu, Sun In Hong, Su Jin Lim, et al.
Pageof 10